Combating rising STI rates
The U.S. Department of Health and Human Services (HHS) released the first-ever national strategic plan to address this dramatic rise in STI in the U.S. According the HHS, the five goals of the strategic plan include preventing STIs, reducing adverse outcomes of STIs, accelerating progress in STI research and innovation, improving STI-related health equity, and achieving coordinated efforts to combat the STI epidemic.2 With unparalleled diagnostic and drug development capabilities, Labcorp is uniquely positioned to help combat rising STI rates in alignment with this national strategic plan.